Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.

Limited placebo-controlled data are available to assess the long-term fracture efficacy of bisphosphonates. In order to determine the effects of 5 years of risedronate treatment, we extended a 3-year, placebo-controlled vertebral fracture study in osteoporotic women for an additional 2 years; women...

Bibliografiset tiedot
Päätekijät:	Sorensen, O, Crawford, G, Mulder, H, Hosking, D, Gennari, C, Mellstrom, D, Pack, S, Wenderoth, D, Cooper, C, Reginster, J
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2003

Samankaltaisia teoksia

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
Tekijä: Cooper, C, et al.
Julkaistu: (2001)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
Tekijä: Raja Bobba, et al.
Julkaistu: (2007-10-01)

Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.
Tekijä: Seeman, A, et al.
Julkaistu: (2000)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
Tekijä: Ma. Florencia Peralta, et al.
Julkaistu: (2021-05-01)

Histomorphometric Quantitative Evaluation of Long-Term Risedronate Use in a Knee Osteoarthritis Rabbit Model
Tekijä: Silvia Fernández-Martín, et al.
Julkaistu: (2021-04-01)

No Effect of Long-Term Risedronate Use on Cartilage and Subchondral Bone in an Experimental Rabbit Model of Osteoarthritis
Tekijä: Silvia Fernández-Martín, et al.
Julkaistu: (2020-11-01)

The mobile study long-term extension: Progressive improvements in efficacy with oral ibandronate (150mg) when administered monthly
Tekijä: Reginster, J, et al.
Julkaistu: (2007)

Once-monthly risedronate for postmenopausal osteoporosis
Tekijä: Kristina Casadei, et al.
Julkaistu: (2009-02-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
Tekijä: Paula Rackoff
Julkaistu: (2009-05-01)

Efficacy of risedronate in a post-menopausal woman affected by osteoporosis and inflammatory bowel disease
Tekijä: Stefano Palomba, et al.
Julkaistu: (2010-06-01)

Risedronate-loaded aerogel scaffolds for bone regeneration
Tekijä: Nahla El-Wakil, et al.
Julkaistu: (2023-12-01)

Effect of risedronate on bone loss at discontinuation of denosumab
Tekijä: Michel Laroche, et al.
Julkaistu: (2020-12-01)

Risedronate inhibits human osteosarcoma cell invasion
Tekijä: Jung Sung, et al.
Julkaistu: (2009-07-01)

Preparation of Risedronate Nanoparticles by Solvent Evaporation Technique
Tekijä: Eliska Vaculikova, et al.
Julkaistu: (2014-11-01)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
Tekijä: Diane Kleinermans, et al.
Julkaistu: (2022-06-01)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
Tekijä: Watts, N, et al.
Julkaistu: (2004)

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
Tekijä: Seeman, E, et al.
Julkaistu: (2010)

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
Tekijä: Kashemirov, B, et al.
Julkaistu: (2008)

The Potential of Bisphosphonate Risedronate Hydrogel in Preventing Relapse Movement
Tekijä: Utari, Tita Ratya, et al.
Julkaistu: (2022)

Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
Tekijä: Abdurrahman Yeter, et al.
Julkaistu: (2014-12-01)

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
Tekijä: Roelofs, A, et al.
Julkaistu: (2005)

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
Tekijä: Marma, MS, et al.
Julkaistu: (2007)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
Tekijä: María J Moro-Álvarez, et al.
Julkaistu: (2008-06-01)

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes
Tekijä: Coxon, F, et al.
Julkaistu: (2008)

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes
Tekijä: Coxon, F, et al.
Julkaistu: (2008)

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
Tekijä: Duncan, E, et al.
Julkaistu: (2005)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
Tekijä: Yohei Asada, et al.
Julkaistu: (2019-01-01)

The Effects of Risedronate Treatment on the Pain and the Quality of Life - Original Investigation
Tekijä: Evrim Karadağ Saygı, et al.
Julkaistu: (2009-08-01)

Development of Risedronate-Loaded Nano Capsules for Calvaria Healing in Rabbit
Tekijä: Hesam Aldin Hoseinzadeh, et al.
Julkaistu: (2019-04-01)

A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis
Tekijä: Satoshi Soen, et al.
Julkaistu: (2020-12-01)

Disturbance of osteonal bone remodeling and high tensile stresses on the lateral cortex in atypical femoral fracture after long-term treatment with Risedronate and Alfacalcidol for osteoporosis
Tekijä: Fumitaka Hirano, et al.
Julkaistu: (2021-06-01)

Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
Tekijä: Bala, Y, et al.
Julkaistu: (2014)

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial
Tekijä: Shaun G. Goodman, et al.
Julkaistu: (2023-09-01)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Tekijä: Jean-Yves Reginster, et al.
Julkaistu: (2014-02-01)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Tekijä: Tahir Masud, et al.
Julkaistu: (2009-11-01)

Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits
Tekijä: Shabnam Aghayan, et al.
Julkaistu: (2021-03-01)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
Tekijä: Vincenzo Monda, et al.
Julkaistu: (2017-09-01)

Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis
Tekijä: Brounais-Le Royer, B, et al.
Julkaistu: (2012)

Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats.
Tekijä: Tingjun Ye, et al.
Julkaistu: (2017-01-01)

Effectiveness of Short-Term Use Denosumab and Risedronate Using β-Crosslaps and Histopathology as a Parameter in Osteoporotic Rat Model
Tekijä: Afrisya Bimo Siwendro, et al.
Julkaistu: (2024-09-01)